These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10577306)

  • 21. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
    Luddington R; Jackson A; Pannerselvam S; Brown K; Baglin T
    Thromb Haemost; 2000 Feb; 83(2):204-8. PubMed ID: 10739373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk?
    André E; Hacquard M; Alnot Y; de Maistre E; Lecompte T
    Thromb Haemost; 2007 Sep; 98(3):693-4. PubMed ID: 17849066
    [No Abstract]   [Full Text] [Related]  

  • 23. Deep vein thrombosis and pulmonary embolism: a single disease entity with different risk factors?
    Perrier A
    Chest; 2000 Nov; 118(5):1234-6. PubMed ID: 11083667
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated protein C resistance: the most common risk factor for venous thromboembolism.
    Sheppard DR
    J Am Board Fam Pract; 2000; 13(2):111-5. PubMed ID: 10764192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A; Dahm AE; Jacobsen AF; Mowinckel MC; Sandvik L; Sandset PM
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism in asymptomatic carriers of factor V Leiden mutation from symptomatic families: any role for hormonal replacement treatment?
    Procare Group
    J Thromb Haemost; 2003 Jun; 1(6):1325-6. PubMed ID: 12871343
    [No Abstract]   [Full Text] [Related]  

  • 29. Broadsheet number 53: Activated protein C resistance: diagnosis and clinical management.
    Baker RI; Eikelboom J; Street A
    Pathology; 1999 Nov; 31(4):365-71. PubMed ID: 10643007
    [No Abstract]   [Full Text] [Related]  

  • 30. Attention--grapefruit!
    Grande LA; Mendez RD; Krug RT; Verschuyl EJ
    Lancet; 2009 Apr; 373(9670):1222. PubMed ID: 19345832
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor V Leiden and venous thromboembolism.
    Murphy PT
    Ann Intern Med; 2004 Sep; 141(6):483-4. PubMed ID: 15381529
    [No Abstract]   [Full Text] [Related]  

  • 32. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiology patient page. Factor V Leiden.
    Ornstein DL; Cushman M
    Circulation; 2003 Apr; 107(15):e94-7. PubMed ID: 12707252
    [No Abstract]   [Full Text] [Related]  

  • 34. Venous thromboembolism during pregnancy is not associated with persistent elevated activated protein C (APC) sensitivity ratio based on the endogenous thrombin potential.
    Zotz RB; Gerhardt A; Kluft C; Scharf RE
    Thromb Haemost; 2005 Feb; 93(2):306-10. PubMed ID: 15711747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of factor V Leiden carriage on maternal and fetal health.
    Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
    CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Zotz RB
    Thromb Haemost; 2003 Jul; 90(1):77-85. PubMed ID: 12876629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
    Elice F; Fink L; Tricot G; Barlogie B; Zangari M
    Br J Haematol; 2006 Aug; 134(4):399-405. PubMed ID: 16882132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal thrombosis.
    Chalmers EA
    J Clin Pathol; 2000 Jun; 53(6):419-23. PubMed ID: 10911798
    [No Abstract]   [Full Text] [Related]  

  • 39. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.